Abstract
LB-2 | VEGF Gene Therapy Improves Exercise Time, Ischemia, and Symptoms in Patients with Refractory Angina: Results of the Phase II EXACT Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have